SCHEMBL6537582

SCHEMBL6537582

CCc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1CN1CCN(C)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CRHBP P24387 1/20 0.40
HTT P42858 1/20 0.40
CRHR2 Q13324 1/20 0.40
GHSR Q92847 1/20 0.39
NPC1 O15118 2/20 0.35
LCK P06239 1/20 0.35
MAPK14 Q16539 1/20 0.35
JAK2 O60674 2/20 0.35
JAK1 P23458 2/20 0.35
TYK2 P29597 2/20 0.35
PDCD1 Q15116 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
THRB P10828 1/20 0.34
POLB P06746 2/20 0.33
CDK14 O94921 1/20 0.33
CCNY Q8ND76 1/20 0.33
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8472529 0.84 MEN1 (0.38) MEN1KMT2ASMN1; SMN2CRHBPHTT
SCHEMBL6537711 0.81 TYK2 (0.42) MEN1KMT2ASMN1; SMN2CRHBPHTT
SCHEMBL6537622 0.81 TYK2 (0.42) MEN1KMT2ASMN1; SMN2CRHBPHTT
SCHEMBL6537705 0.80 MEN1 (0.37) MEN1KMT2ASMN1; SMN2CRHBPHTT
SCHEMBL6537581 0.80 SLC16A3 (0.42) MEN1KMT2ASMN1; SMN2CRHBPHTT
SCHEMBL6538125 0.79 SLC16A3 (0.41) MEN1KMT2ASMN1; SMN2CRHBPHTT
SCHEMBL6537482 0.78 SMN1; SMN2 (0.46) MEN1KMT2ASMN1; SMN2CRHBPHTT
SCHEMBL6537354 0.78 MEN1 (0.44) MEN1KMT2ASMN1; SMN2CRHBPHTT
SCHEMBL6537856 0.78 TYK2 (0.40) MEN1KMT2ASMN1; SMN2CRHBPHTT
SCHEMBL6537806 0.78 JAK2 (0.40) MEN1KMT2ASMN1; SMN2CRHBPHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed